PubMed · 3509340
Antihypertensive ergoline derivatives.
Abstract
Novel ergolines were synthesized and screened in spontaneous hypertensive rats (SHR) with the aim of finding a new class of ergot related antihypertensives. Their prolactin inhibitory effect (measured as nidation inhibition in rats), acute toxicity (LD50) and interference with CNS function (Irwin test) were also evaluated as a measure of selectivity and safety. Modification of the C8 side-chain enhanced antihypertensive activity selectively, while the introduction of substituents in other positions of the ergoline skeleton generally yielded unfavourable results, either by decreasing selectivity or by increasing toxicity.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
S Mantegani, A Temperilli, G Traquandi, P Salvati, E Di Salle, E Lamberti, A Bonsignori. 1987. Antihypertensive ergoline derivatives.. https://pubmed.ncbi.nlm.nih.gov/3509340/
Cite the original work for its findings. Save a collection to share your selection of sources.